Core Viewpoint - Perpetua Resources Corp. (PPTA) shows potential for further upside, with a mean price target of $25.73 indicating a 27.2% increase from the current price of $20.23 [1] Price Targets - The average price target consists of five estimates ranging from a low of $21.00 to a high of $30.00, with a standard deviation of $3.68, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 3.8% increase, while the highest suggests a 48.3% upside [2] Analyst Sentiment - There is strong agreement among analysts regarding PPTA's ability to report better earnings than previously predicted, which supports the view of potential upside [4] - The Zacks Consensus Estimate for the current year has increased by 16% over the past month, with one estimate rising and no negative revisions [12] Zacks Rank - PPTA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be wise due to historical inaccuracies in predicting stock price movements [3][7][10] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated estimates [8]

Core Insights - Harrow, Inc. has garnered investor attention with a recent price target of $70 set by Thomas Flaten from Lake Street, indicating a potential increase of approximately 48.62% from the current stock price of $47.10 [1] - The company held its Analyst/Investor Day on September 26, 2025, where key executives provided insights into its strategic direction and financial outlook, attended by analysts from notable firms [2] - The stock price of HROW has recently increased by $0.95, or 2.06%, with a trading range on the same day between $46.29 and $50.72, reflecting significant volatility over the past year [3] - Harrow's market capitalization stands at approximately $1.74 billion, with a trading volume of 1,326,594 shares, indicating strong investor interest and potential upside [4]

Core Viewpoint - US Gold Corp (USAU) has shown a significant price increase of 13.3% over the past four weeks, with a mean price target of $19.5 indicating a potential upside of 29% from the current price of $15.12 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $4.27, where the lowest estimate is $15.00 (indicating a 0.8% decline) and the highest estimate is $23.50 (indicating a 55.4% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - There is a strong consensus among analysts regarding the company's ability to report better earnings, with a 17.8% increase in the Zacks Consensus Estimate for the current year [11][12] - USAU holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to potential biases and inflated targets set by analysts [3][8][10]

Group 1 - Photronics (PLAB) shares have increased by 11.1% over the past four weeks, closing at $24.73, with a mean price target of $31.65 indicating a potential upside of 28% [1] - The mean estimate includes three short-term price targets with a standard deviation of $1.51, where the lowest estimate suggests a 21.3% increase and the highest indicates a 33.2% surge [2] - Analysts show a strong consensus that PLAB will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for PLAB has increased by 7.7% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - PLAB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for price movement [14]

Core Viewpoint - MBX Biosciences, Inc. (MBX) shares have increased by 44% in the past four weeks, closing at $20, with a mean price target of $37.71 indicating a potential upside of 88.6% according to Wall Street analysts [1] Price Targets and Analyst Estimates - The mean estimate consists of seven short-term price targets with a standard deviation of $4.23, where the lowest estimate is $30.00 (50% increase) and the highest is $44.00 (120% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, indicating less variability in their estimates [2][9] Earnings Estimates and Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has risen by 2.7% over the past month, with one estimate increasing and no negative revisions [12] Zacks Rank and Investment Potential - MBX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Core Viewpoint - Edgewise Therapeutics, Inc. (EWTX) shows significant upside potential with a mean price target of $39.17, indicating an 182% increase from the current price of $13.89 [1][11]. Price Targets and Estimates - The mean estimate consists of 12 short-term price targets with a standard deviation of $12.96, suggesting variability among analysts [2]. - The lowest estimate is $14.00, indicating a modest 0.8% increase, while the highest estimate is $51.00, reflecting a potential surge of 267.2% [2]. - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9]. Earnings Estimates - Analysts have shown increasing optimism about EWTX's earnings prospects, with a strong consensus on higher EPS estimates [11]. - The Zacks Consensus Estimate for the current year has increased by 1% over the past month, with one estimate rising and no negative revisions [12]. - EWTX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Analyst Behavior and Price Target Reliability - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated estimates [8]. - While price targets can provide insights, they should be approached with skepticism as they may not accurately predict stock price movements [10].

Company Overview - EVI Industries, Inc. specializes in the distribution and service of commercial laundry and dry cleaning equipment, operating in a niche market that serves industries such as hospitality, healthcare, and education [1] Financial Performance - On September 10, 2025, EVI's Q4 2025 earnings call provided insights into the company's financial results and future plans, with CEO Henry Nahmad discussing strategic growth initiatives [2][5] - The current stock price of EVI is $27.99, reflecting a slight increase of 0.74% or $0.205, with a trading range today between $27.96 and $28.39 [3] - Over the past year, EVI's stock has fluctuated between a high of $29.29 and a low of $14.99, indicating volatility in market performance [3] Market Position and Outlook - Michael Shlisky from D.A. Davidson has set a price target of $33 for EVI, suggesting a potential increase of approximately 17.65% from its current price [2][5] - The market capitalization of EVI is approximately $357.18 million, highlighting its significant presence in the commercial laundry equipment sector [3] - The current trading volume for EVI is 1,409 shares, indicating relatively low trading activity, which may be attributed to the niche nature of the industry or investor caution following the recent earnings call [4]

Core Viewpoint - Mission Produce, Inc. (AVO) shows potential for significant upside, with a mean price target of $17.33 indicating a 34.9% increase from the current trading price of $12.85 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $0.58, suggesting a consensus among analysts [2] - The lowest estimate of $17.00 indicates a 32.3% increase, while the highest target of $18.00 suggests a 40.1% increase from the current price [2] - Analysts' price targets can be misleading, as they often set overly optimistic targets influenced by business relationships [7][8] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism regarding AVO's earnings, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [11] - Over the last 30 days, one estimate has increased, leading to a 15.7% rise in the Zacks Consensus Estimate for the current year [12] - AVO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of AVO's potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Electromed, Inc. (ELMD) has shown a significant price increase of 26.2% over the past four weeks, with a mean price target of $36.33 indicating a potential upside of 52.1% from the current price of $23.88 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $1.53, where the lowest estimate is $35.00 (46.6% increase) and the highest is $38.00 (59.1% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9] Analyst Optimism and Earnings Estimates - Analysts have shown increasing optimism about ELMD's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [11] - Over the last 30 days, two earnings estimates have been revised upward, leading to a 4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - ELMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While the consensus price target may not be entirely reliable, the implied direction of price movement appears to be a good guide for potential investment [14]

Group 1 - Knightscope, Inc. (KSCP) shares have increased by 4.7% over the past four weeks, closing at $5.82, with a mean price target of $15.33 indicating a potential upside of 163.4% [1] - The mean estimate includes three short-term price targets with a standard deviation of $9.45, where the lowest estimate of $8.00 suggests a 37.5% increase, and the highest estimate of $26.00 indicates a potential surge of 346.7% [2] - Analysts show a strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 18.2% over the past month, indicating positive earnings prospects for KSCP [11][12] Group 2 - KSCP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside in the near term [13] - While price targets can be misleading, the direction indicated by the consensus price target may serve as a useful guide for potential price movement [10][14]